Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
MarketResearch.biz delivers in-depth insights on the global anti-venom market in its upcoming report titled, “Global Anti-Venom Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global anti-venom market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global anti-venom market report has been segmented on the basis of anti-venom type, product type, end user, and region.
Venom is a poisonous fluid secreted by animal such as snakes, scorpions, and spiders, the toxicity can be varied based upon species. Anti-venom neutralizes the poisonous and releases the venom from the receptor site. Bites by venomous snakes can cause paralysis, irreversible kidney failure, and local tissue destruction that can cause permanent disability. Anti-venom products are made by fractionating the blood from sheep or horse, which is further hyper immunized with snake venom. Anti-venom products are available in lyophilized or liquid forms.
Increasing prevalence of snake bites, scorpion bites or other insect bites in developing and undeveloped economics are factors expected to fuel the growth of global anti-venom market over the forecast period. Furthermore, deforestation has enabled human to come in close proximity with poisonous animal thus increasing demand for efficient and effective treatment which in turn is expected to drive the market growth of global anti-venom market over the forecast period. Rising government finding for development of high quality anti venom products in turn is expected to boost the market growth of the anti-venom market over the forecast period.
However, lack of consistent quality during production of anti-venom and high manufacturing cost are major factors restraining the growth of global anti-venom market.
According to World Health Organization (WHO) data for 2017, approximately 81,000 to 138,000 people die every year as a result of snake bites. Furthermore, approximately 5.4 million people are bitten by snake each year with up to 2.7 million envenoming. In December 2015, WHO started a initiative to evaluate the potential safety and effectiveness of current anti-venom products intended for use in sub-Saharan Africa. Children and people working in farms are mostly affected by venom of snakes, scorpions, and spiders. Developing countries from Latin America, and Asia Pacific are expected to contribute major share of the market over the forecast period.
Global anti-venom market segmentation;
By anti-venom type:
- Monovalent Anti-venom
- Polyvalent Anti-venom
By product type:
- Snake anti venom
- Scorpion anti-venom
- Spider anti venom
By end user:
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Sigma Aldrich
- Bharat Serums and Vaccines Limited
- Micropaharm Limited
- Haffkine Bio-Pharmaceutical Corporation Ltd
- Rare Therapeutics, Inc.
- Vins Bioproducts Limited
- Incepta Vaccine Ltd.
- Medtoxin Venom Laboratories, LLC
- CSL Behring
- BTG International Ltd.
Request for TOC
Don't just take our word. We are trusted by these great companies!